ADIM
TGT icon

Alpha DNA Investment Management’s Target TGT Stock Holding History

Alpha DNA Investment Management’s Portfolio TGT Stock Details TGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,530
Closed -$833K – 235
2023
Q3 		$833K Buy
+7,530
New +$956K 0.34% 54
2021
Q4 		– Sell
-7,244
Closed -$1.66M – 147
2021
Q3 		$1.66M Buy
+7,244
New +$1.81M 1.13% 18
2021
Q2 		– Sell
-404
Closed -$79K – 595
2021
Q1 		$79K Buy
404
+105
+35% +$19.7K 0.09% 134
2020
Q4 		$52K Buy
+299
New +$49.9K 0.06% 178

Other funds holding TGT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alpha DNA Investment Management's TGT Position: Q4 2023 in Review

Alpha DNA Investment Management sold out of Target (TGT) in Q4 2023, closing a stake of 7,530 shares — an estimated $833K sold.

Alpha DNA Investment Management first reported a position in TGT in Q4 2020 and held it in 4 quarters. The position peaked at $1.66M in Q3 2021. 1,952 funds tracked by Wall St. Rank hold TGT as of Q4 2023.

  • Alpha DNA Investment Management reported no remaining Target position as of Q4 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 7,530 Target shares in Q4 2023, an estimated $833K.
  • Alpha DNA Investment Management first reported a position in Target in Q4 2020 and held it in 4 quarters.
  • Alpha DNA Investment Management's Target position peaked at $1.66M in Q3 2021.
  • 1,952 funds tracked by Wall St. Rank held Target as of Q4 2023.

Based on Alpha DNA Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.